Ludwig Hantson
Director/Board Member bij HOLOGIC, INC.
Vermogen: 864 732 $ op 31-03-2024
Profiel
Ludwig N. Hantson bekleedt de functie van Chief Executive Officer & Director bij Alexion Pharmaceuticals, Inc. Hij zit ook in de Raad van Bestuur van Hologic, Inc. en Biotechnology Innovation Organization. Dr. Hantson bekleedde voorheen de functie van President-BioScience Division bij Baxter International, Inc. Chief Executive Officer bij Synovis Life Technologies, Inc. en President bij Baxter BioScience Corp. (beide dochtermaatschappijen van Baxter International, Inc.), Principal bij Johnson & Johnson, President-Pharma Canada bij Novartis AG en Chief Executive Officer-Pharma North America bij Novartis Pharmaceuticals Corp. (een dochteronderneming van Novartis AG), President, Chief Executive Officer & Director bij Baxalta, Inc. en Principal bij Smith & Nephew NV. Ludwig N. Hantson behaalde een doctoraat en een graduaatsdiploma aan de Universit Catholique de Louvain.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
HOLOGIC, INC.
0.00% | 07-03-2024 | 11 092 ( 0.00% ) | 864 732 $ | 31-03-2024 |
Actieve functies van Ludwig Hantson
Bedrijven | Functie | Begin |
---|---|---|
HOLOGIC, INC. | Director/Board Member | 21-11-2018 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Eerdere bekende functies van Ludwig Hantson
Bedrijven | Functie | Einde |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Chief Executive Officer | 21-07-2021 |
BAXALTA INC | Chief Executive Officer | 03-06-2016 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01-07-2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-05-2010 |
NOVARTIS AG | Corporate Officer/Principal | 01-01-2010 |
Opleiding van Ludwig Hantson
Université Catholique de Louvain | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
HOLOGIC, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
NOVARTIS AG | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Synovis Life Technologies, Inc.
Synovis Life Technologies, Inc. Medical SpecialtiesHealth Technology Synovis Life Technologies, Inc. manufactures medical devices. It markets biological and mechanical products used by surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company was founded in July 1985 and is headquartered in St. Paul, MN. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
Smith & Nephew NV/SA
Smith & Nephew NV/SA Medical SpecialtiesHealth Technology Smith & Nephew NV engages in the development of medical technologies. It offers advanced wound management and advanced surgical devices. The company was founded on April 13, 2001 and is headquartered in Zaventem, Belgium. | Health Technology |